New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
SGLT-2 inhibitors show mixed results after heart attack

SGLT-2 inhibitors show mixed results after heart attack

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainWhile the composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce hea
Breakthroughs April 28,2024
SGLT-2 inhibitors show mixed results after heart attack

SGLT-2 inhibitors show mixed results after heart attack

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainWhile the composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce hea
Breakthroughs April 28,2024
A closed-loop drug-delivery system could improve chemotherapy

A closed-loop drug-delivery system could improve chemotherapy

by Anne Trafton,Massachusetts Institute of TechnologyTo make chemotherapy dosing more accurate, MIT engineers have come up with a way to continuously measure how much drug is in the patient’s sy
Breakthroughs April 28,2024
A closed-loop drug-delivery system could improve chemotherapy

A closed-loop drug-delivery system could improve chemotherapy

by Anne Trafton,Massachusetts Institute of TechnologyTo make chemotherapy dosing more accurate, MIT engineers have come up with a way to continuously measure how much drug is in the patient’s sy
Breakthroughs April 28,2024
Study finds AI can develop treatments to prevent 'superbugs'

Study finds AI can develop treatments to prevent 'superbugs'

byCleveland ClinicSchematic evolutionary simulation and tested optimization approaches. Credit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2303165121Clev
Breakthroughs April 28,2024
Study finds AI can develop treatments to prevent 'superbugs'

Study finds AI can develop treatments to prevent 'superbugs'

byCleveland ClinicSchematic evolutionary simulation and tested optimization approaches. Credit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2303165121Clev
Breakthroughs April 28,2024
Circadian rhythms can influence drugs' effectiveness

Circadian rhythms can influence drugs' effectiveness

by Anne Trafton,Massachusetts Institute of TechnologyPrimary human hepatocytes display a circadian rhythm in culture. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adm9281Giving
Breakthroughs April 28,2024
Circadian rhythms can influence drugs' effectiveness

Circadian rhythms can influence drugs' effectiveness

by Anne Trafton,Massachusetts Institute of TechnologyPrimary human hepatocytes display a circadian rhythm in culture. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adm9281Giving
Breakthroughs April 28,2024
Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half

Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAmong patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to s
Breakthroughs April 28,2024
Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half

Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAmong patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to s
Breakthroughs April 28,2024
Geraniol attenuates oxidative stress and cognitive impairment in mouse aging model

Geraniol attenuates oxidative stress and cognitive impairment in mouse aging model

by Impact Journals LLCEffect of GNL on D-gal-induced cognitive impairment mice by using99mTc-HMPAO (brain) animal imaging. Credit:Aging(2024). DOI: 10.18632/aging.205677A new researc
Neurology April 28,2024
Geraniol attenuates oxidative stress and cognitive impairment in mouse aging model

Geraniol attenuates oxidative stress and cognitive impairment in mouse aging model

by Impact Journals LLCEffect of GNL on D-gal-induced cognitive impairment mice by using99mTc-HMPAO (brain) animal imaging. Credit:Aging(2024). DOI: 10.18632/aging.205677A new researc
Neurology April 28,2024
ACC: Empagliflozin cuts heart failure hospitalization risk after AMI

ACC: Empagliflozin cuts heart failure hospitalization risk after AMI

by Elana GotkineFor patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6
Cardiovascular Diseases April 28,2024
ACC: Empagliflozin cuts heart failure hospitalization risk after AMI

ACC: Empagliflozin cuts heart failure hospitalization risk after AMI

by Elana GotkineFor patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6
Cardiovascular Diseases April 28,2024
Magic mushrooms can treat medication-resistant depression—but are they safe?

Magic mushrooms can treat medication-resistant depression—but are they safe?

by Leigh Hataway,University of GeorgiaCredit: CC0 Public DomainNew research suggests psilocybin has similar side effects to traditional antidepressants. Commonly referred to as "magic mushr
Breakthroughs April 28,2024
Magic mushrooms can treat medication-resistant depression—but are they safe?

Magic mushrooms can treat medication-resistant depression—but are they safe?

by Leigh Hataway,University of GeorgiaCredit: CC0 Public DomainNew research suggests psilocybin has similar side effects to traditional antidepressants. Commonly referred to as "magic mushr
Breakthroughs April 28,2024
It's easier now to treat opioid addiction with medication—but use has changed little, study finds

It's easier now to treat opioid addiction with medication—but use has changed little, study finds

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainFor years, even as opioid overdose deaths dramatically increased, doctors and other prescribers in the United States needed special perm
Breakthroughs April 28,2024
It's easier now to treat opioid addiction with medication—but use has changed little, study finds

It's easier now to treat opioid addiction with medication—but use has changed little, study finds

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainFor years, even as opioid overdose deaths dramatically increased, doctors and other prescribers in the United States needed special perm
Breakthroughs April 28,2024
Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

by Stephanie Lopez,Duke UniversityCredit: Pixabay/CC0 Public DomainAbout 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. T
Cardiovascular Diseases April 28,2024
Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

by Stephanie Lopez,Duke UniversityCredit: Pixabay/CC0 Public DomainAbout 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. T
Cardiovascular Diseases April 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com